Evidence map›Paper›PMID 40999799›Full record

ArticleProteomics2025

Chemoproteomic Profiling of Reactive Cysteines in Response to Oxidative Stress Induced by 6-Hydroxydopamine.

Rayan Murtada, Chiho Kim, Xu-Dong Wang, Youkai Yang, Yonghao Yu

Abstract read
In one paragraph

Article in Proteomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rayan MurtadaDepartment of Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.ORCID 0000-0001-5747-0204
Chiho KimDepartment of Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Xu-Dong WangDepartment of Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.ORCID 0000-0002-8265-1485
Youkai YangDepartment of Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Yonghao YuDepartment of Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

Funding

Multiplexed Quantification of the Protein Poly-ADP-Ribosylation Landscape in C9ORF72-ALS/FTDR01NS137290 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Shuying Sun, Yonghao Yu · 2024 to 2026
$2.2M
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular CondensationR01NS122533 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI Yonghao Yu · 2022 to 2026
$2.0M
Genome and Epigenome Integrity In CancerT32CA265828 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Alberto Ciccia, Chao Lu · 2022 to 2026
$1.8M
NCI NIH HHS T32 CA265828NIH HHS 1R01NS122533NIH HHS 5T32CA265828-03NIH HHS R01NS137290NINDS NIH HHS R01 NS122533NINDS NIH HHS R01 NS137290
6 · The paper itself

Abstract

Although oxidative stress is a well-established driver of neurodegeneration, it remains poorly understood as to how the global cysteine (Cys) proteome is remodeled under oxidative stress conditions. Proteins with aberrantly modified cysteines in response to oxidative stress can induce and exacerbate neurodegeneration, contributing to disorders like Alzheimer's, Parkinson's, frontotemporal dementia, and amyotrophic lateral sclerosis. In this study, we induced oxidative stress in SH-SY5Y neuronal cells by subjecting them to the neurotoxin 6-hydroxydopamine (6-OHDA). To identify proteins with altered cysteine oxidation or PTM status, we used a desthiobiotin iodoacetamide (DBIA) probe, which selectively labels cysteines with unmodified and preserved thiols. Using these unbiased chemoproteomic strategies, we identified proteins with reduced Cys reactivity to DBIA in response to 6-OHDA-induced oxidative stress. Many of these proteins are critically involved in biological processes linked to cell stress responses (e.g., mitochondrial oxidative stress and apoptosis). Furthermore, we found that two key Cys on UCHL1 (a deubiquitinase critically involved in neurodegeneration) exhibited enhanced reactivity under oxidative stress conditions. Our study defines the remodeling of the Cys proteome under 6-OHDA-induced oxidative stress conditions. Furthermore, these findings suggest potential cysteine-mediated regulatory mechanisms in response to oxidative stress, providing a valuable resource for further exploration of cysteine modifications in the context of neurodegenerative signaling.

Indexed as

CysteineOxidative StressOxidopamineProteomeProteomicsCell Line, TumorHumansIodoacetamideNeuronsOxidation-ReductionUbiquitin ThiolesteraseCysteineIodoacetamideOxidopamineProteomeUbiquitin ThiolesteraseUCHL1 protein, human6‐hydroxydopaminecysteine proteomeneurodegenerationoxidative stressposttranslational modifications

Identifiers

PMID40999799
PMCPMC12522117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.